Network of European Funding for Neuroscience Research (NEURON) – Pre-Proposal
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with Unit
Memorial Deadline: Inquire with RGCS
External Deadline: Monday 11th, March 2019
Description
NOTE: The pre-proposal submission deadline to the NEURON Joint Call Secretariat is March 11, 2019 14:00 (C.E.T).
The ‘Network of European Funding for Neuroscience Research’ (NEURON) was established under the ERA-NET scheme of the European Commission. The aim of ERA-NET NEURON is to coordinate and optimize research efforts and funding programmes of its partner countries in the fields of disease related neuroscience.
Under the umbrella of NEURON, a joint transnational call (JTC2019) has been launched for biomarkers in disorders of the brain. For afflicted patients, a correct diagnosis and individualized treatment without severe side effects are of crucial importance. Despite impressive improvement on our knowledge of brain function, valid and reliable biomarkers for clinical and research use in the field of brain diseases are still urgently needed. Brain disease biomarkers candidates are continuously identified and published by academic research groups. However, the rigorous validation of those promising candidates as research or clinical tools is seriously hindered by the frequent use of poorly standardized practices.
CIHR and the NEURON funding organizations particularly wish to promote multi-disciplinary work and translational research proposals that combine basic and clinical approaches. In the context of the present call, the inclusion of psychiatrists and/or neurologists in the proposed teams is highly encouraged, along with fundamental neuroscientists. The teams are expected to submit novel, ambitious ideas that can only be achieved by the complementary collaboration between partners.
Research Areas
Research proposals should cover at least one of the following areas:
- Fundamental research addressing the discovery and validation of biomarkers to be used as bio-signatures of the pathophysiology associated to specific neurological and psychiatric diseases
- Clinical research on clinically relevant biomarkers for the diagnosis, patient stratification, prognosis or monitoring or prediction of treatment response and side effects for specific neurological and psychiatric diseases
For more information please consult the ERA-NET NEURON website.
Funds Available
CIHR and partner(s) financial contributions for this initiative are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or are decreased due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.
- The total amount available from CIHR for the Canadian component of this funding opportunity is $450,000 enough to fund approximately 2 grants.
- The maximum amount per grant is $75,000 per year for up to 3 years for a total of $225,000 per grant.
- Funds are available for one Canadian component per consortium.
Full program details are available through ResearchNet.